Back to News
Market Impact: 0.1

Monday 10/5 Insider Buying Report: LPCN, CSWC

Source: Nasdaq

Insider Transactions

The article introduces two recent insider stock purchases, noting that an SEC filing showed a buy by Lipocine director John W. Hig—; the text cuts off before giving the transaction details. No purchase amount, share count, or information about the second buy is available.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.10

Ticker Sentiment

LPCN0.30

More News

From AllMind Research

Browse all research